3,4-dihydroxyphenylacetic acid has been researched along with naloxone in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (46.15) | 18.7374 |
| 1990's | 9 (23.08) | 18.2507 |
| 2000's | 7 (17.95) | 29.6817 |
| 2010's | 5 (12.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fadda, F; Gessa, GL; Porceddu, ML; Stefanini, E | 1 |
| Biggio, G; Casu, M; Corda, MG; Di Bello, C; Gessa, GL | 1 |
| Nowycky, MC; Roth, RH; Walters, JR | 1 |
| Bläsig, J; Gramsch, C; Herz, A | 1 |
| Kim, C; Van Loon, GR | 1 |
| De Montis, GM; Di Lorenzo, C; Olianas, MC; Tagliamonte, A | 1 |
| Cebeira, M; Fernández-Ruiz, JJ; Hernández, ML; Navarro, M; Ramos, JA; Rodriguez de Fonseca, F | 1 |
| Ishikawa, K; Kogure, M; Kubo, T; Shibanoki, S | 1 |
| Berridge, CW; Dunn, AJ | 1 |
| Artinián, J; Cancela, LM; Fulginiti, S | 1 |
| Aizenstein, ML; Lebrun, FL; Lebrun, I | 1 |
| Holman, RB; Snape, BM; Widdowson, PS | 1 |
| Böhm, E; Hurth, S; Muscholl, E; Racké, K | 1 |
| Hiramatsu, M; Kameyama, T; Noma, S; Ukai, M | 1 |
| Wilkes, MM; Yen, SS | 1 |
| Richard, JW; Wood, PL | 1 |
| Alper, RH; Demarest, KT; Moore, KE | 1 |
| Curell, J; Hitzemann, R; Hom, D; Loh, H | 1 |
| Barbaccia, ML; Reggiani, A; Spano, PF; Trabucchi, M | 1 |
| McMillen, BA | 1 |
| Cappai, F; Colombo, G; Devoto, P; Gessa, GL | 1 |
| Ahtee, L; Piepponen, TP | 1 |
| Berger, SP; Broderick, PA; Hsu, K; Reid, MS; Souza, KH | 1 |
| Huang, NK; Tseng, CJ; Tung, CS; Wong, CS | 1 |
| Borg, PJ; Taylor, DA | 1 |
| De Natale, G; Desole, MS; Enrico, P; Esposito, G; Miele, E; Miele, M; Migheli, R; Mura, MA; Serra, P | 1 |
| Laorden, ML; Milanés, MV | 1 |
| Fuertes, G; Laorden, ML; Milanés, MV | 1 |
| Fuente, T; Laorden, ML; Milanés, MV | 1 |
| Ho, IK; Tokuyama, S; Yamamoto, T | 1 |
| Nyberg, F; Zhou, Q | 1 |
| Andrews, ZB; Grattan, DR | 1 |
| Desole, MS; Dessanti, G; Miele, E; Miele, M; Migheli, R; Rocchitta, G; Serra, PA; Susini, G | 1 |
| Bregonzio, C; Deis, RP; Penissi, A; Soaje, M; Valdez, S | 1 |
| Barson, JR; Hoebel, BG; Leibowitz, SF; Rada, P | 1 |
| Górski, K; Misztal, T; Romanowicz, K; Tomaszewska-Zaremba, D | 1 |
| Dong, H; Gong, Z; Yan, L; Yong, Z; Yu, G; Zhou, P | 1 |
| García-Pérez, D; Laorden, ML; Milanés, MV; Núñez, C; Sáez-Belmonte, F | 1 |
| García-Pérez, D; Laorden, ML; López-Bellido, R; Milanés, MV; Núñez, C; Rodríguez, RE | 1 |
1 review(s) available for 3,4-dihydroxyphenylacetic acid and naloxone
| Article | Year |
|---|---|
Ethanol effects on dopaminergic function: modulation by the endogenous opioid system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Endorphins; Ethanol; Humans; Mice; Mice, Inbred Strains; Naloxone; Narcotic Antagonists; Receptors, Dopamine; Retina; Species Specificity; Spiperone | 1980 |
38 other study(ies) available for 3,4-dihydroxyphenylacetic acid and naloxone
| Article | Year |
|---|---|
Effect of trazodone on brain dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Chemistry; Dopamine; Homovanillic Acid; Male; Mice; Naloxone; Piperazines; Rats; Time Factors; Trazodone | 1976 |
Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Endorphins; Enkephalins; Homovanillic Acid; Kainic Acid; Male; Naloxone; Rats; Receptors, Dopamine; Receptors, Opioid | 1978 |
Dopaminergic neurons: effect of acute and chronic morphine administration on single cell activity and transmitter metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dihydroxyphenylalanine; Male; Morphine; Naloxone; Neurons; Rats; Synaptic Transmission; Tyrosine | 1978 |
Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzomorphans; Catechol O-Methyltransferase; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Male; Monoamine Oxidase; Morphine; Naloxone; Probenecid; Rats; Substance Withdrawal Syndrome; Time Factors; Tyramine | 1977 |
Dopaminergic mediation of beta-endorphin-induced catalepsy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain Chemistry; Catalepsy; Corpus Striatum; Dopamine; Drug Synergism; Endorphins; Haloperidol; Humans; Male; Naloxone; Rats | 1978 |
Failure of morphine to increase striatal 3,4-dihydroxyphenylacetic acid in fasted rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Fasting; Male; Morphine; Naloxone; Phenylacetates; Rats; Stimulation, Chemical | 1978 |
Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Brain Chemistry; Corpus Striatum; Cyclic AMP; Dopamine; Kinetics; Male; Mice; Morphine; Morphine Dependence; Motor Activity; Naloxone; Receptors, Dopamine D1; Receptors, Dopamine D2; Synapses | 1992 |
Naloxone affects both pharmacokinetics and pharmacodynamics of morphine. Application of direct correlation analysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Corpus Striatum; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Protein Binding; Rats; Rats, Inbred Strains; Statistics as Topic; Sulfobromophthalein | 1991 |
Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Biogenic Amines; Brain; Catecholamines; Chromatography, High Pressure Liquid; Corticotropin-Releasing Hormone; Dopamine; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; Methoxyhydroxyphenylglycol; Mice; Naloxone; Norepinephrine; Serotonin; Stress, Physiological; Tissue Distribution; Tryptophan | 1987 |
Opioid influence on some aspects of stereotyped behavior induced by repeated amphetamine treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Apomorphine; beta-Endorphin; Corpus Striatum; Dopamine; Male; Morphine; Naloxone; Narcotics; Nucleus Accumbens; Rats; Rats, Inbred Strains; Reference Values; Stereotyped Behavior | 1988 |
Evidence for a role of beta-endorphin in activity of nigrostriatal neurons in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; beta-Endorphin; Corpus Striatum; Dopamine; Homovanillic Acid; Naloxone; Neurons; Phenylacetates; Rats; Substantia Nigra | 1988 |
Naloxone elicits dose-dependent changes in alcohol-induced increases in endogenous dopamine release from rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Ethanol; Homovanillic Acid; Male; Naloxone; Rats; Rats, Inbred Strains; Sleep | 1987 |
Endogenous opioids inhibit the in vitro release of endogenous dopamine preferentially in the neural lobe of the rat neurointermediate lobe.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Electric Stimulation; Endorphins; Female; Homovanillic Acid; Naloxone; Pituitary Gland; Rats; Secretory Rate; Vasopressins | 1986 |
Differential effects of alpha-, beta- and gamma-endorphins on dopamine metabolism in the mouse brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Endorphin; Animals; beta-Endorphin; Brain; Cerebral Cortex; Corpus Striatum; Dopamine; Endorphins; gamma-Endorphin; Homovanillic Acid; Male; Muridae; Naloxone | 1982 |
Reduction by beta-endorphin of efflux of dopamine and DOPAC from superfused medial basal hypothalamus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; beta-Endorphin; Depression, Chemical; Dopamine; Endorphins; Female; Hypothalamus; Hypothalamus, Middle; Male; Naloxone; Phenylacetates; Rats; Sex Factors | 1980 |
Morphine and nigrostriatal function in the rat and mouse: the role of nigral and striatal opiate receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Morphine; Naloxone; Rats; Rats, Inbred Strains; Receptors, Opioid; Species Specificity; Substantia Nigra | 1982 |
Morphine differentially alters synthesis and turnover of dopamine in central neuronal systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Limbic System; Male; Median Eminence; Morphine; Naloxone; Neurons; Nucleus Accumbens; Pituitary Gland, Posterior; Rats | 1980 |
Effects of naloxone on d-amphetamine- and apomorphine-induced behavior.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Behavior, Animal; Brain; Dextroamphetamine; Dopamine; Drug Interactions; Humans; Male; Naloxone; Rats; Rats, Inbred Strains; Spiperone; Stereotyped Behavior | 1982 |
On the mechanism of morphine action on rat striatal dopamine metabolsim.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Dopamine; Female; Haloperidol; In Vitro Techniques; Morphine; Naloxone; Rats | 1980 |
Naloxone antagonizes ethanol- but not gamma-hydroxybutyrate-induced sleep in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Ethanol; Injections, Subcutaneous; Male; Mice; Naloxone; Sleep; Sodium Oxybate | 1994 |
Effects of selective opioid receptor antagonists on morphine-induced changes in striatal and limbic dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Pain Threshold; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu | 1995 |
Neuropharmacological characterization of local ibogaine effects on dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ibogaine; Male; Microdialysis; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 1996 |
Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Evaluation, Preclinical; Glutamic Acid; Male; Microdialysis; Morphine; Naloxone; Nerve Endings; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |
Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Analysis of Variance; Anesthetics, Inhalation; Animals; Chromatography, High Pressure Liquid; Dopamine; Drug Interactions; Halothane; Homovanillic Acid; Injections, Intravenous; Male; Microdialysis; Morphine; Naloxone; Narcotic Antagonists; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu | 1997 |
Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Ascorbic Acid; Corpus Striatum; Dopamine; Glutamic Acid; Homovanillic Acid; Hydroxyindoleacetic Acid; Locomotion; Male; Microdialysis; Morphine; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Substantia Nigra; Uric Acid | 1998 |
Effects of U-50,488H withdrawal on catecholaminergic neurones of the rat ventricle.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Heart Ventricles; Male; Naloxone; Neurons; Norepinephrine; Normetanephrine; Rats; Rats, Sprague-Dawley | 1998 |
Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Chronic Disease; Corticosterone; Cyclic AMP; Dopamine; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Norepinephrine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2000 |
Catecholaminergic activity and 3',5'-cyclic adenosine monophosphate levels in heart right ventricle after naloxone induced withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catecholamines; Cyclic AMP; Dopamine; Heart Ventricles; Male; Morphine Dependence; Myocardium; Naloxone; Narcotic Antagonists; Norepinephrine; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome | 2000 |
A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Butorphanol; Cerebral Cortex; Corpus Striatum; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Mesencephalon; Morphine; Naloxone; Opioid-Related Disorders; Protein Kinase Inhibitors; Protein Kinases; Rats; Rats, Sprague-Dawley | 2000 |
Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Extracellular Space; Male; Microdialysis; Morphine Dependence; Naloxone; Narcotic Antagonists; Neural Pathways; Nucleus Accumbens; Peptide Fragments; Presynaptic Terminals; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Substance P; Substance Withdrawal Syndrome; Up-Regulation; Ventral Tegmental Area | 2002 |
Opioid control of prolactin secretion in late pregnant rats is mediated by tuberoinfundibular dopamine neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arcuate Nucleus of Hypothalamus; Dopamine; Female; Hypothalamo-Hypophyseal System; Labor, Obstetric; Median Eminence; Naloxone; Narcotic Antagonists; Neural Inhibition; Neurons; Opioid Peptides; Pregnancy; Prolactin; Rats; Rats, Sprague-Dawley; Up-Regulation | 2002 |
Effects of sufentanil on the release and metabolism of dopamine and ascorbic acid and glutamate release in the striatum of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Ascorbic Acid; Corpus Striatum; Dopamine; Glutamic Acid; Homovanillic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Male; Microdialysis; Movement; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Sufentanil; Uric Acid | 2003 |
Dopaminergic mechanisms involved in prolactin release after mifepristone and naloxone treatment during late pregnancy in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Enzyme Inhibitors; Female; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Hormone Antagonists; Hydrazines; Hypothalamus; Mifepristone; Naloxone; Narcotic Antagonists; Pregnancy; Pregnancy, Animal; Prolactin; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2006 |
Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Analgesics, Opioid; Animals; Dopamine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Methionine; Homovanillic Acid; Male; Microdialysis; Microinjections; Morphine; Naloxone; Narcotic Antagonists; Neural Pathways; Nucleus Accumbens; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley | 2010 |
Opioid-salsolinol relationship in the control of prolactin release during lactation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Suckling; Brain; Dopamine; Female; Isoquinolines; Lactation; Naloxone; Narcotic Antagonists; Prolactin; Receptors, Opioid, mu; Sheep | 2010 |
Effects of thienorphine on release of dopamine and noradrenalin: an in vivo microdialysis study in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Buprenorphine; Corpus Striatum; Dopamine; Locus Coeruleus; Male; Microdialysis; Naloxone; Norepinephrine; Nucleus Accumbens; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2012 |
Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Argonaute Proteins; Body Weight; Dopamine; Drug Implants; Gene Expression Regulation; Homeodomain Proteins; Injections, Intraperitoneal; Male; Mesencephalon; Morphine; Naloxone; Nuclear Receptor Subfamily 4, Group A, Member 2; Nucleus Accumbens; Phosphorylation; Rats; Rats, Wistar; Substance-Related Disorders; Transcription Factors; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2013 |
Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Disease Models, Animal; Dopamine; Gene Expression Regulation; Homeodomain Proteins; Imaging, Three-Dimensional; Male; Microscopy, Confocal; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Nuclear Receptor Subfamily 4, Group A, Member 2; Rats; Rats, Wistar; RNA, Messenger; Transcription Factors; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2015 |